To Top

Community

Cynthia A. Challener, Ph.D.

Dr. Challener is an established industry editor and technical writing expert in the areas of chemistry and pharmaceuticals. She writes for various corporations and associations, as well as marketing agencies and research organizations, including That’s Nice and Nice Insight.

Contribution
Genetics

New Genetic Understanding Could Lead to Brain Cancer Treatments

PAO-M09-18-NI-017
Oncology

EU Gives Nod to KEYTRUDA and Chemotherapy Combination Treatment

PAO-M09-18-NI-009
Drug Development

Sanofi-Aventis Collaborates with Dyadic International on Cl Gene Expression

PAO-M09-18-NI-007
FDA Approval

Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval

PAO-M09-18-NI-003
FDA Approval

AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment

PAO-M08-18-NI-027
Drug Pricing

New Senate Bill Includes Amendment on Drug Pricing in Ads for Prescription Meds

PAO-M08-18-NI-026
Drug Approval

Fast Approval for Roche Drug Alecensa in China

PAO-M08-18-NI-023
Drug Development

SPR Therapeutics’ Single- and Dual-Lead Peripheral Nerve Stimulation Devices Pass FDA

PAO-M08-18-NI-021
FDA

Brainsway’s Transcranial Magnetic Stimulation System Gets FDA Clearance

PAO-M08-18-NI-019
Facility

Groundbreaking for Amgen in Rhode Island

PAO-M08-18-NI-017
Regulatory

China to Accelerate Review of 48 Foreign Drugs

PAO-M08-18-NI-013
CRO

From Internal Lab to External Service Provider

PAO-M08-18-NI-009
Drug Delivery

Exosomes Explored as New Option in Drug Delivery

PAO-M08-18-NI-008
FDA Analysis

FDA Analysis Shows Reduced Competition for First-in-Class Drugs

PAO-M08-18-NI-002
Drug Pricing

Are Rebates Contributing to Higher Drug Prices?

PAO-M08-18-NI-001
FDA

FDA to Import Drugs from Other Countries

PAO-M07-18-NI-018
Announcement

Shire Exec Selected to Run Servier Pharmaceuticals U.S.

PAO-M07-18-NI-015
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

PAO-M07-18-NI-011
Investment

Women’s Health Company to Expand

PAO-M07-18-NI-007
Investment

Organ-on-a-Chip Company Raises $36 Million

PAO-M07-18-NI-005
Announcement

Alcon Set Out On its Own

PAO-M07-18-NI-002
Immunotherapy

India Gets First Immunotherapy for Lung Cancer

PAO-M06-18-NI-022
Investment

Successful IPO for Verrica Pharmaceuticals

PAO-M06-18-NI-018
CAR-T Therapy

Cellectic CAR-T Therapy Contains Safety Switch and More

PAO-M06-18-NI-017
Drug Development

China Grants First Approval for PD-1/L1 Checkpoint Inhibitor

PAO-M06-18-NI-014
Cell and Gene Therapy

Will Rapid Genome Sequencing Become A Standard Practice for Acutely Ill Infants?

PAO-M06-18-NI-012
Market Expansion

BluePrint Medicines Targets Asian Market

PAO-M06-18-NI-002
Next-Generation Drug Development

Challenges for Next-Generation Biological Therapeutics Discovery and Development

PAP-Q2-18-FA-001
Next-Generation Manufacturing

Thinking a Generation Ahead: Biologics-Based Therapy

PAP-Q2-18-FA-002
Next-Generation Packaging

Finishing Touches – The Future of Fill-Finish and Pharma Packaging

PAP-Q2-18-FA-003
FDA Approval

FDA Approves New Migraine Treatment

PAO-M05-18-NI-014
Acquisition

Eli Lilly Makes Two Acquisitions in the Oncology Space

PAO-M05-18-NI-008
Biosimilars

GlobalData Predicts Strong Sales for Humira Biosimilars in Europe

PAO-M05-18-NI-006
Survey Data

Good News for Cancer Survivors

PAO-M04-18-NI-022
Preclinical Data

Encouraging Preclinical Data for Anticancer Drugs Reported by Verseon

PAO-M04-18-NI-019
Drug Candidate

STA Pharmaceutical Co. to Manufacture Phoenix Molecular Designs’ Anticancer Candidate

PAO-M04-18-NI-018
Clinical Trials

Eli Lilly Gets Good News for Cyramza

PAO-M04-18-NI-009
Strategic Collaboration

Compugen, MedImmune to Collaborate on Bi- and Multi-Specific Antibodies

PAO-M04-18-NI-007
Cell and Gene Therapy

New Stem Cell Therapy Approved in Europe

PR-M03-18-NI-102
Drug Development

More Good News for Novo Nordisk’s Semaglutide and Weight Loss

PAO-M03-18-NI-024
Cannibis

Medical Marijuana Moves to the Big Time

PAO-M03-18-NI-019
Discovery

A New Landscape: M&A in the Discovery & Research Sector

PAP-Q1-18-NI-002
Fill/Finish

Getting to the Finish Line

PAP-Q1-18-NI-004
Sponsor

What’s Driving M&A Among Pharma Sponsors?

PAP-Q1-18-NI-003
CAR-T

Pfizer Joins Gilead in CAR-T Development   

PAO-M01-18-NI-044
Supplier

Abzena Selects Sartorius Stedum Biotech as Supplier of Single-Use Tech

PAO-M01-18-NI-033
Expansion

Abzena Continues to Expand Globally

PAO-M01-18-NI-025
Acquistion

Mallinckrodt Expands Rare Disease Pipeline with Sucampo Acquisition

PAO-M01-18-NI-017
CFDA

China FDA Publishes Guidance for Priority Review

PAO-M01-18-NI-013
DNA

New Method Could Provide Super Resolution for Biological Imaging

PAO-M12-17-NI-040
Regulatory

No Clinically Meaningful Difference: The Upward Trend of Biosimilars

PAP-Q4-17-FA-001
Innovation

Moving Beyond Monoclonal Antibodies

PAP-Q4-17-FA-002
Automation

Pharma’s Automation Index on the Rise

PAP-Q4-17-FA-003
FDA

GSK Shingles Vaccine Recommended for Approval by FDA Panel

PAO-M09-17-NI-027
Manufacturing

New Manufacturing Paradigms in an Evolving Pharma Industry: Partnering in the Equipment Space Across Channels

PAP-Q3-17-FA-003
CRO

Building Strategic Sponsor-CRO Partnerships: The International Element Changing Clinical Trials

PAP-Q3-17-FA-002
CDMO

The CDMO and the International Supply Chain: How Global and Local Relationships are Guiding Sponsors and Providers

PAP-Q3-17-FA-001
Partnership

Samsung to Develop Novel Drugs

PAO-M09-17-NI-002
FDA

The FDA Reauthorization Act Passes the U.S. Senate

PAO-M08-17-NI-026
NDA

New Drug Approved to Prevent Hereditary Angioedema Attacks Now Available in the US

PAO-M08-17-NI-006
Investment

Chinese Genetics Company Completes Successful IPO

PAO-M07-17-NI-032
Innovation

Can Cells Replace Computers?

PAO-M07-17-NI-027
Innovation

New Sickle Cell Treatment Approved

PAO-M07-17-NI-014
Innovation

Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments

PAO-M07-17-NI-007
CDMO

Biopharmaceutical Manufacturing Goes Mainstream

PAP-Q2-17-FA-004
Expansion

New Report Predicts Singapore Pharma Market Worth More Than $1 Billion by 2019

PAO-M06-17-NI-022
Innovation

Number of New Collaborations Announced by Johnson & Johnson Innovation

PAO-M06-17-NI-014
Clinical Trials

Checkmate Pharmaceuticals Receives Series B Funding for CMP-001

PAO-M06-17-NI-013
Innovation

Eli Lilly, KeyBioscience Agree to Work on the Development of New Diabetes Drugs

PAO-M06-17-NI-011
Biosimilar

Pfizer Gets FDA Advisory Committee Nod for Biosimilar

PAO-M06-17-NI-002
Biologics

Making Strides: Biologics Push Forward

PAP-Q2-17-FA-001
Clinical Trials

Clinical Trials Find a Device for Growth

PAP-Q2-17-FA-002
Drug Delivery

The Search for Alternative Delivery Methods Continues

PAP-Q2-17-FA-003
Oral Solid Dosage

Nice Symposium Oral Solid Dose 2017: Bringing the Supply Chain Together to Tackle Development Challenges

PAP-Q2-17-NS-001
Acquisition

Bioverativ to Acquire True North

PAO-M05-17-NI-038
Immuno-Oncology‎

Bristol-Meyers Squibb, Array BioPharma Enter Strategic Collaboration

PAO-M05-17-NI-036
CDMO

Boehringer Ingelheim Expands its Contract Manufacturing in China

PAO-M05-17-NI-029
CDMO

Orphan Xermelo Begins Commercial Manufacture

PAO-M05-17-NI-018
Clinical Trials

AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases

PAO-M05-17-NI-011
Innovation

Millipore Sigma Sponsoring LabCentral

PAO-M05-17-NI-002
Acquisition

Sawai Pharmaceutical Acquires Upsher‐Smith Generics Business

PAO-M04-17-NI-029
CDMO

Famar Expands Into North America

PAO-M04-17-NI-019
Logistics

Merck and Bristol-Myers Squibb Extend Partnerships with Incyte

PAO-M04-17-NI-005
Clinical Trials

FDA Approves Bavencio for Rare Skin Cancer

PAO-M03-17-NI-002
CDMO

Siegfried Sees Rise in Sales after Acquisitions

PAO-M03-17-NI-017
Patent

European Medical and Pharma Patent Filings Fell in 2016

PAO-M03-17-NI-010
CDMO

The Data Generation

PAP-Q1-17-IN-001
API

Changes in the Wind for the CDMO Market

PAP-Q1-17-FA-002
API

The Search for Practical and Economical Catalysts

PTO-M10-16-NI-001
CDMO

A Foundation of Innovation

PAP-Q04-16-IN-001
CDMO

Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches

PAP-Q04-16-CL-011
CDMO

Collaboration is the Name of the Game

PAP-Q03-16-IN-001
Biopharmaceuticals

Controlling Glycosylation for Improved Product Quality

BIO-M06-16-NI-001
API

Biocatalysis Versus Chemocatalysis

MCP-M04-16-NI-001